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Abstract Macrophages respond to bacterial lipopolysaccharide
(LPS) by activating latent cis-acting factors that initiate
transcription of immediate early genes. One such immediate
early gene, junB, is induced by LPS in macrophages within 30
min. To identify elements that mediate the induction of junB by
LPS, upstream and downstream sequences flanking the junB
gene were examined by transient expression in the RAW264.7
murine macrophage cell line using a luciferase reporter gene
vector containing the junB minimal promoter. A s 10-fold en-
hancement was associated with a 222 bp region downstream of
the junB promoter in response to LPS. Transient reporter
assays demonstrated that multiple nuclear factor (NF) UB sites
are required for inducibility of junB by LPS in RAW264.7 cells.
Electrophoretic mobility shift assays confirmed binding of LPS-
induced nuclear proteins included p50/p65 heterodimers at these
NF-UB sites. ß 2002 Published by Elsevier Science B.V. on
behalf of the Federation of European Biochemical Societies.
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1. Introduction
junB is a member of the bZIP family of transcription fac-
tors, all of which encode proteins with a leucine zipper motif
that mediates dimerizations to constitute active transcription
factors [1]. Dimerization of junB with other jun or fos family
members yields the formation of an active AP-1 complex [1].
Subsequent binding of AP-1 to DNA recognition sequences
results in a cascade-like transcriptional activation of genes
involved in cellular proliferation, di¡erentiation, and activa-
tion. Stimulation of macrophages with bacterial lipopolysac-
charide (LPS) results in an increase in junB mRNA transcripts
and upregulation of AP-1 binding activity [2].
As many genes critical to macrophage activation contain
AP-1 binding sites within their promoters [3^5], we sought
to gain further insight as to how LPS-induced junB gene ex-
pression is controlled using the murine macrophage cell line,
RAW264.7. A transient luciferase expression assay incorpo-
rating the junB promoter was used to screen both upstream
and downstream regions of the junB gene. Herein we report
that LPS-induced transcriptional activation of the junB gene
in RAW264.7 macrophages is controlled by multiple nuclear
factor (NF) UB binding sites within a 222 bp region down-
stream of the junB promoter. Furthermore, the cumulative
e¡ect of these NF-UB sites is due to binding of p50/p65 het-
erodimers.
2. Materials and methods
2.1. Cell culture and electroporation
The RAW264.7 murine macrophage cell line, obtained from the
ATCC (Rockville, MD, USA), was maintained in RPMI 1640/2
mM L-glutamine/10% fetal calf serum/50 WM L-mercaptoethanol
(R10). All plasmids used in electroporation experiments were puri¢ed
in cesium chloride^ethidium bromide gradients. Cells were electropo-
rated with a Cell-Porator (Life Technologies, Grand Island, NY,
USA) at 200 V and 1600 WF on low resistance setting, as recently
described [6]. Eighteen hours post-transfection, cells were stimulated
with or without LPS (1 Wg/ml; Sigma, St. Louis, MO, USA) or mur-
ine interleukin-6 (IL-6, 200 U/ml) [7] for 4 h and then harvested for
luciferase and L-galactosidase assays. Luciferase expression was cor-
rected for the expression of L-galactosidase (pADL) as an internal
control. Inducibility was calculated as the corrected activity of stimu-
lated cells relative to that of untreated cells.
2.2. Stimulation of cells for Northern blot analysis and
Western blot analysis
RAW264.7 cells were stimulated with or without LPS (1 Wg/ml) or
murine IL-6 (200 U/ml) as indicated and harvested by removal of all
medium and subsequent lysis in the appropriate bu¡ers. Total cellular
RNA was isolated using the Qiagen RNeasy kit (Qiagen, Chatsworth,
CA, USA) and Northern blot analysis performed as previously de-
scribed [8]. For Western blot analysis of whole cell lysates, cells were
lysed in RIPA lysis bu¡er (150 WM NaCl, 1% NP-40, 0.5% deoxy-
cholate acid, 0.1% SDS, 50 WM Tris pH 8.0, and 0.5 WM AEBSF).
Samples were analyzed by 8% SDS^PAGE followed by electropho-
retic transfer to polyvinylidene di£uoride membranes (Immobilon-P,
Millipore, Bedford, MA, USA). The membranes were blocked with
1% ovalbumin (Sigma) in 150 mM NaCl, 10 mM Tris, pH 8.0 with
0.05% Tween 20, incubated with a mouse monoclonal antibody di-
rected against junB (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) for 1 h, followed by incubation with a peroxidase-conjugated
goat anti-mouse IgG (Southern Biotechnology Associates, Birming-
ham, AL, USA). Membranes were developed using enhanced chem-
iluminescence (Amersham, Arlington Heights, IL, USA).
2.3. Construction of junB plasmids
The IUB-K dominant-negative plasmid (a generous gift from Dr.
Keith Brown, Laboratory of Immunoregulation, NIAID, NIH, Be-
thesda, MD, USA) has been described previously [9]. The plasmids
used for reporter assays were constructed as previously described [7].
Brie£y, an EcoRI site at 36500 and a SmaI site at +240 were used to
construct pGL2/6.5 by partial SmaI digestion of an 8 kb EcoRI frag-
ment of a clone obtained by screening a genomic BALB/c mouse
library with the junB cDNA. The resulting 6.7 kb fragment was li-
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gated to pGL2Basic (Promega, Madison, WI, USA). A PstI site at
3196 was used to construct pGL2JP by ligation of a 436 bp PstI^
SmaI fragment containing the junB promoter (3196 to +240) to
pGL2Basic. Ligation into a 2.1 kb EcoRI fragment containing
DNA immediately downstream of the junB coding region in the re-
verse orientation into the polylinker upstream of the promoter in
pGL2JP resulted in pGL2JP/2DR. Religation of pGL2JP/2DR di-
gested with SmaI produced pGL2JP/1.5^2.2DR. A 1.3 kb BamHI^
EcoRI fragment was ligated to pGL2JP, resulting in pGL2JP/1.5^
2.8DR. Production of pGL2JP/222DR was by ligation of a down-
stream 222 bp NlaIII^SmaI fragment (within the 2.1 kb EcoRI frag-
ment) in the reverse orientation into the polylinker upstream of the
junB promoter in pGL2JP. The 222 bp fragment was also cloned
downstream of the luciferase gene (pGL2JP/222SF). Mutations of
enhancer sites within the insert of pGL2JP/222SF were constructed
by mutual priming with oligonucleotides containing the desired muta-
tions, followed by ampli¢cation by polymerase chain reaction as pre-
viously described [7].
2.4. Preparation of nuclear extracts
Cells were stimulated with or without 1 Wg/ml LPS for 15 min and
nuclear extracts were prepared as described previously [10]. A small
aliquot was removed to determine protein concentration using Coo-
massie Protein Assay Reagent (Pierce, Rockford, IL, USA). Samples
were frozen on dry ice, and stored at 380‡C until use.
2.5. Electrophoretic mobility shift assays/supershifts
Nuclear extracts were incubated on ice for 1 h with or without the
addition of normal rabbit serum (Ig control), rabbit anti-human p50
polyclonal serum, rabbit anti-human p65 polyclonal serum (a gener-
ous gift from Dr. Nancy Rice, NCI Frederick Cancer Research and
Development Center, NIH, Frederick, MD, USA), or a combination
of anti-p50 and anti-p65. Samples were then incubated with 32P-la-
beled oligonucleotide probe consisting of a double stranded sequence
for each of the four NF-UB sites within the downstream 222 bp region
of the promoter of the junB gene in binding bu¡er (¢nal concentration
of 10 mM Tris pH 7.5, 100 mM NaCl, 1 mM dithiothreitol, 5 mM
EDTA, 4% (v/v) glycerol and 0.08 mg/ml sonicated salmon sperm
DNA). The sequences for these probes are as follows: NF-UB1: 5P-
CGTCAGCGGGGAAAGCCCCCGGCGCACT-3P ; NF-UB2: 5P-G-
GGCAGATTCCGGGAATCCCCTCCCCCC-3P ; NF-UB3: 5P-GCC-
TGCTCGGGAAAATCCCGGCCCCCTT-3P ; NF-UB4: 5P-CCCGG-
GCCTGGGGCTTTCCGCGCCAGAA-3P.
An NF-UB consensus oligonucleotide (Promega) was used as a pos-
itive control in these experiments. Samples were applied to a 6% non-
denaturing PAGE gel (Novex, San Diego, CA, USA) to separate free
probe from probe bound to protein.
3. Results and discussion
To document the kinetics of junB expression at both the
transcriptional and translational levels, RAW264.7 cells were
stimulated with or without 1 Wg/ml LPS for di¡erent periods
of time. As shown in Fig. 1A, junB mRNA was induced in
RAW264.7 cells and peaked at approximately 1 h post-stim-
ulation, while junB protein production was maximally ele-
vated at 3^4 h (Fig. 1B). Based upon the observed kinetic
pattern, a 4 h stimulation time point was chosen for subse-
quent reporter assays. In contrast, IL-6 (200 U/ml), another
known stimulus for junB gene expression in macrophages [11]
and plasmacytomas [12], induced both junB gene expression
(Fig. 1C) and protein production (Fig. 1D) to a lesser extent
than that induced by LPS.
To determine the regions of the junB promoter that were
necessary for LPS-induced junB gene expression, RAW264.7
cells were transiently transfected with either the junB pro-
moter (JP) alone, or the JP plus either a 6.5 kb upstream
region, or a 2 kb downstream region. Eighteen hours post-
transfection, cells were treated with or without LPS and har-
vested 4 h later for reporter assays. As shown in Fig. 2A,
transfection with the 6.5 kb upstream region had only a mod-
est e¡ect on LPS inducibility of junB (2.4-fold increase). In
contrast, transfection with the 2 kb downstream region of the
junB promoter resulted in a 5.4-fold induction of junB expres-
sion compared to JP itself.
In order to locate the region responsible for LPS-induced
junB gene expression, di¡erent fragments of the 2 kb down-
stream region were analyzed. As shown in Fig. 2B, the 1.5^2.8
region and the 1.5^2.2 region showed 24.0-fold and 23.3-fold
inductions, respectively, suggesting that activity in this region
was located within the 1500^2200 downstream fragment. The
pGL2JP/222DR construct showed a 19.1-fold increase in
LPS-induced junB promoter activity. No elevation in LPS-in-
ducible junB promoter activity was observed using the
pGL2JP/1547^2047DR construct, suggesting that the 1547^
2047 bp downstream region does not additively contribute
to activation of the promoter by LPS treatment.
Fig. 1. junB induction in the murine macrophage cell line, RAW264.7. A: Northern blot analysis of the kinetics of junB gene expression in
LPS (1 Wg/ml)-stimulated RAW264.7 macrophages. B: Western blot analysis of junB protein production in LPS (1 Wg/ml)-stimulated
RAW264.7 macrophages. Northern blot analysis (C) and Western blot analysis (D) of junB expression in LPS (1 Wg/ml)- or IL-6-treated (200
U/ml) RAW264.7 macrophages.
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We previously reported that IL-6-inducible junB expression
in murine plasmacytoma cells was due to the same 222 bp
region downstream of the junB promoter [7]. Therefore, the
222 bp region of junB appears to serve as a regulatory region
for multiple responses, whose speci¢city relates to both the
stimulus and the transcription factors involved. The
pGL2JP/222 region contains several di¡erent transcriptional
regulation elements. In order to determine which transcription
factors might be activating junB in response to LPS, con-
structs with mutated transcriptional binding sites were made
and compared in their ability to activate the junB promoter.
As shown in Fig. 2C, single mutations in either the ¢rst or
third NF-UB binding sites substantially decreased junB pro-
moter activity in response to LPS (12.5-fold and 6.2-fold in-
duction by LPS vs. 19.4). A mutation in the second NF-UB
site slightly reduced junB promoter activity (14.6-fold induc-
tion by LPS vs. 19.4). When either the ¢rst three NF-UB sites
or all four sites were simultaneously mutated, LPS-induced
junB promoter activity was reduced to almost baseline levels.
Mutations in any other sites did not substantially alter LPS-
induced junB promoter activity (data not shown). These re-
sults suggest that multiple NF-UB sites within the junB pro-
moter contribute to LPS induction of junB gene expression in
RAW264.7 cells.
To con¢rm that these NF-UB sites could bind NF-UB pro-
teins, nuclear extracts were prepared from LPS-stimulated
RAW264.7 cells and binding determined by electrophoretic
mobility shift assay using 32P-labeled oligonucleotides speci¢c
for each of the four putative NF-UB sites (Fig. 3). Oligonu-
cleotides directed against any of the four NF-UB sites bind to
proteins from LPS-activated RAW264.7 macrophages. Ex-
tracts were also incubated with polyclonal antibodies speci¢c
for the p50 and p65 subunits of NF-UB to determine which
NF-UB subunits bound to the junB promoter. As demon-
strated, these proteins are composed of p50/p65 heterodimers.
While all four sites in the 222 bp region bind to p50/p65
heterodimers in LPS-activated RAW264.7 cells, the ¢rst and
third NF-UB elements appear essential for the majority of
LPS-mediated activation of junB transcription.
To determine whether NF-UB activity contributes to LPS-
induced activation of junB transcription, RAW264.7 cells were
co-transfected with the pGL2JP/222 plasmid or the pGL2JP/
222 plasmid with all four mutated NF-UB sites (pGL2JP/
vNF1234SF) on conjunction with an IUB-K construct con-
taining point mutations in serine residues 32 and 36. These
mutations prevent IUB-K from undergoing signal-induced
phosphorylation and degradation, and thus the subsequent
activation of NF-UB [9]. Eighteen hours post-transfection,
RAW264.7 cells were stimulated with or without LPS or IL-
6 and harvested 4 h later for reported assays. As demon-
strated in Fig. 4, inhibition of NF-UB activation via a domi-
nant-negative IUB-K construct substantially inhibited (approx-
imately 60%) LPS-induced junB transcription in cells co-
transfected with the pGL2JP/222 construct containing the
four intact NF-UB sites. In contrast, cells co-transfected
with pGL2JP/222 containing the four mutated NF-UB sites
were not activated by LPS.
Bacterial LPS contributes to the pathology of sepsis by its
ability to stimulate the functional activation and synthesis of
in£ammatory mediators by cells of the monocytic lineage.
One of the genes induced by LPS is junB. JunB, itself a com-
ponent of the AP-1 transcription factor complex, regulates the
expression of multiple e¡ector genes important for cell prolif-
eration, di¡erentiation, and survival. Our data demonstrate
that LPS induces junB transcription via the binding of NF-
UB p50/p65 heterodimers to multiple NF-UB consensus se-
quences within a downstream 222 bp region of the junB pro-
moter. In quiescent cells, NF-UB is retained in the cytoplasm
in its inactive form by the inhibitor protein, IUB-K, which
strongly associates with p50/p65 heterodimers. Upon stimula-
Fig. 2. LPS inducibility of the junB gene. RAW264.7 cells were
transfected by electroporation with 1 pmol of a luciferase reporter
gene vector containing the junB promoter alone (pGL2JP) or di¡er-
ent £anking regions as described below. After electroporation, cells
were rested overnight and two aliquots were treated with or without
LPS (1 Wg/ml). Luciferase expression was corrected for the expres-
sion of pADL as an internal control. Inducibility was calculated as
the corrected activity of stimulated cells relative to that of untreated
cells. The results represent three independent experiments, each us-
ing separate plasmid preparations. A: LPS inducibility of the junB
gene within a 2 kb downstream £anking sequence of junB. Cells
were transfected with 1 pmol of a luciferase reporter gene vector
containing the junB promoter alone (pGL2JP), the 6.5 kb upstream
£anking region, or the 2 kb downstream £anking region. B: LPS in-
ducibility of the junB gene within a 222 bp downstream £anking se-
quence of junB. Cells were transfected with 1 pmol of a luciferase
reporter gene vector containing the junB promoter alone (pGL2JP),
or di¡erent segments of the 2 kb downstream £anking region:
pGL2JP/1.5^2.8, pGL2JP/1.5^2.2, pGL2JP/1547^2047 pGL2JP/222
(1018^2249). C: E¡ect of site-directed mutations of transcription
factor sites contained within the 222 bp downstream £anking se-
quence of junB on LPS inducibility. Mutations of the di¡erent tran-
scription factor binding sites within the pGL2JP/222 plasmid were
created as previously described.
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Fig. 3. Binding of NF-UB p50 and p65 subunits to NF-UB sites within the 222 bp region of the junB promoter. Nuclear extracts were prepared
from RAW264.7 cells that were stimulated with or without LPS (1 Wg/ml) for 15 min using oligonucleotide probes for each of the four NF-UB
sites within the 222 bp region. Binding assays were performed with normal rabbit serum, anti-p50 antibody, anti-p65 antibody, or anti-
p50+anti-p65 antibodies. The results shown are representative of four independent experiments.
Fig. 4. A dominant-negative IUB-K inhibits LPS inducibility of the junB gene. RAW264.7 cells were transfected by electroporation with or with-
out 1 pmol of the IUB-K dominant-negative vector and 1 pmol of a luciferase reporter gene vector containing the pGL2JP/222SF plasmid or
the plasmid with all four mutated NF-UB sites (pGL2JP/vNF1234SF). After electroporation, cells were rested overnight and two aliquots were
treated with or without LPS (1 Wg/ml) or murine IL-6 (200 U/ml). Luciferase expression was corrected for the expression of pADL as an inter-
nal control. Inducibility was calculated as the corrected activity of stimulated cells relative to that of untreated cells. The results are representa-
tive of three independent experiments, each using separate plasmid preparations.
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tion by various pathogens or stress, IUB-K is phosphorylated
and rapidly degraded, allowing NF-UB translocation to the
nucleus, and initiating the transcription of target genes, such
as junB. By use of the dominant-negative IUB-K mutant, we
were able to demonstrate that LPS activates junB transcrip-
tion in RAW264.7 cells via the NF-UB pathway. The UB
DNA consensus sequence for binding of p50/p65 heterodimers
(GGG ACT TTCC) [13] is recognized by both p50 homo-
dimers and p50/p65 heterodimers and, at high concentrations,
by p65 homodimers. The p50 component of this heterodimer
preferentially binds to the 5P region of the recognition se-
quence GGGRN, whereas the p65 component binds to the
3P region of the recognition sequence TTCC [14,15]. Of the
four di¡erent NF-UB sites within the junB promoter, both the
NF-UB1 and the NF-UB3 sites exhibit sequence homology for
a high a⁄nity binding site for p50/p65 heterodimer complexes,
consistent with our results from gel supershift assays. In con-
trast, the NF-UB2 and NF-UB4 sites lack the TTCC sequence
for optimal p65 interaction, which could explain the limited
contribution of these two sites to junB gene transcription.
Both the NF-UB1 and NF-UB3 sites appear essential for
strong activation of the junB gene following LPS activation,
suggesting a cumulative functional interaction between the
protein complexes bound to these sites. Promoter regions of
other proin£ammatory genes have similar multiple transcrip-
tion factor binding sites that together allow for maximal tran-
scriptional activation of these genes [16,17]. It is plausible that
the multiplicity of binding sites in junB and other genes may
help to form a multimeric complex whose tertiary and/or
quaternary structure potentiates transcriptional activation.
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